Nancy Hepp, Laura Pole, and Host Michael Lerner
Three Surprisingly Effective Complementary Cancer Therapies: Aspirin, Vitamin D, and Melatonin
Join The New School Host and CancerChoices Co-founder Michael Lerner for a webinar conversation with CancerChoices Program Manager and Lead Researcher Nancy Hepp and Senior Clinical Consultant Laura Pole. After a brief discussion of using natural products and re-purposed drugs in integrative cancer care, they will explore the surprisingly good evidence of effectiveness for improving survival and reducing risk of cancer for three complementary therapies: aspirin, vitamin D, and melatonin.
Host Michael Lerner
Michael is the president and co-founder of Commonweal. His principal work at Commonweal is with the Cancer Help Program, CancerChoices.org, the Omega Resilience Projects, the Collaborative on Health and the Environment, and The New School at Commonweal. He was the recipient of a MacArthur Prize Fellowship for contributions to public health in 1983 and is author of Choices in Healing: Integrating the Best of Conventional and Complementary Therapies (MIT Press).
